These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17062391)

  • 21. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
    Chang C; Hong SW; Dua P; Kim S; Lee DK
    Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knocking down disease with siRNAs.
    Dykxhoorn DM; Lieberman J
    Cell; 2006 Jul; 126(2):231-5. PubMed ID: 16873051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
    Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
    Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi-based drug discovery and its application to therapeutics.
    Hokaiwado N; Takeshita F; Banas A; Ochiya T
    IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoinduced RNA interference.
    Matsushita-Ishiodori Y; Ohtsuki T
    Acc Chem Res; 2012 Jul; 45(7):1039-47. PubMed ID: 22360585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations of the 3' protruding ends in synthetic short interfering RNA (siRNA) tested by microinjection in Drosophila embryos.
    Boutla A; Delidakis C; Livadaras I; Tabler M
    Oligonucleotides; 2003; 13(5):295-301. PubMed ID: 15000820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.
    Davis ME; Zuckerman JE; Choi CH; Seligson D; Tolcher A; Alabi CA; Yen Y; Heidel JD; Ribas A
    Nature; 2010 Apr; 464(7291):1067-70. PubMed ID: 20305636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
    Li T; Wu M; Zhu YY; Chen J; Chen L
    Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle-based delivery system for application of siRNA in vivo.
    Wang Y; Li Z; Han Y; Liang LH; Ji A
    Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA delivery for the treatment of ovarian cancer.
    Goldberg MS
    Methods; 2013 Sep; 63(2):95-100. PubMed ID: 23403216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.